Fiche société
Second Xiangya Hospital of Central South University
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| CM355This study was designed to investigate the safety and efficacy of CM355 in patients with refractory SLE. | Lupus | Non applicable | À vérifier | China | À vérifier |
| CM355This study was designed to investigate the safety and efficacy of CM355 in patients with refractory SLE. | Lupus | Non applicable | À vérifier | China | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| CM355 | Lupus | Non applicable | NCT07104344 | Study of CM355 in Patients With Systemic Lupus Erythematosus | ACTIVE_NOT_RECRUITING |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||